MedinCell
Sustainability Report and Carbon Intensity Rankings
Is MedinCell doing their part?
Their DitchCarbon score is 39
MedinCell has a DitchCarbon Score of 39 out of 100, indicating room for improvement in its sustainability practices. This score reflects a moderate level of carbon intensity in the company’s operations. To enhance its sustainability efforts, MedinCell needs to focus on reducing its carbon footprint and adopting greener initiatives.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
MedinCell operates within the health and social services industry, which has a low carbon intensity ranking. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Medium
High
Very high
MedinCell is situated in France, a country with a very low carbon intensity rating. This favorable environmental context supports the company’s sustainability efforts by reducing its carbon footprint.
Unlock 30+ emissions data points on MedinCell
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on MedinCell
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
2.56%
...this company is doing 2.56% worse in emissions than the industry average.
MedinCell, founded in 2002 and headquartered in Montpellier, operates within the health and social services industry. The company specializes in developing innovative drug delivery technologies to enhance patient care and treatment efficacy, particularly in controlled release medications. MedinCell is committed to creating affordable, best-in-class medicines, focusing on improving patient safety, compliance, and optimizing treatment outcomes through strong collaborations and a patient-centered approach.
emission intelligence's platform recommendations for MedinCell
MedinCell should foster sustainability practices throughout their supply chain to achieve a significant reduction in their Scope 3 emissions.
Bad news, MedinCell hasn't committed to SBTi goals yet
MedinCell has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company is either in the process of defining its climate action goals or has yet to align its emissions reduction strategies with the SBTi’s rigorous criteria.
Not participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.